BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2004
View Archived Issues
Bavarian Nordic highlights Imvamune progress
Read More
Polyvalent vaccine reported to improve survival in advanced melanoma
Read More
Novel fructose 1,6-bisphosphatase inhibitor lowers blood glucose in vivo
Read More
GPC Biotech achieves significant progress in anticancer drug programs during first quarter
Read More
Treatment options for restless legs syndrome
Read More
Dopamine D4 receptor agonist ABT-724 may offer safe and effective treatment of erectile dysfunction
Read More
NCX-911 may benefit ED patients with dysfunctional endogenous NO production
Read More
Enzon strengthens pipeline during Q3 through Onco TCS addition
Read More
Clinical efficacy of a BAY-43-9006 combination regimen in advanced melanoma
Read More
Vasogen updates Celacade phase III program
Read More
Disappointing preliminary phase IIa results for NGD-2000-1 in RA
Read More
FDA approves Rapinex powder for oral suspension 20 mg
Read More
Sepracor resubmits Estorra NDA
Read More
OSI and Genentech sign new Tarceva agreements
Read More
Second phase III trial of phenserine for Alzheimer's disease
Read More
Emisphere initiates new trial to select oral form of unfractionated heparin
Read More
Efaproxyn and Revaproxyn, new trade names for efaproxiral
Read More
New phase III hemodialysis trial for ferumoxytol iron replacement therapy
Read More
Phase II trial of Xcytrin for recurrent low-grade NHL under way
Read More
Labopharm to apply polymeric nanodelivery systems technology to cancer drug
Read More
Noven and Shire to proceed with further development of MethyPatch
Read More
Insegia chosen as trade name for G17DT
Read More
FDA accepts for filing Surfaxin NDA
Read More
Analgesic efficacy of HCT-3012 in osteoarthritis of the knee
Read More
Novel ecstasy analogues may be promising antiparkinsonian agents
Read More
Febuxostat reported to reduce serum urate levels of gout patients
Read More
Four series of delta opioid ligands prepared by AstraZeneca scientists
Read More
Antiangiogenic HARP-derived peptides newly developed at CNRS
Read More
New indole-based androgenic agents covered by Akzo Nobel patent
Read More
New macrolides able to potentiate the activity of antifungal azoles
Read More
Takeda claims novel neurotrophic factor production enhancers
Read More
New CDK inhibitors in early development at Banyu
Read More
Non-antibacterial macrolides with potential as antiiflammatory agents
Read More
Novel IL-8 receptor antagonists and their use described by GSK
Read More